Cells, cytokines and inflammatory bowel disease: a clinical perspective (Q37948155)

25 August 2017

title

Cells, cytokines and inflammatory bowel disease: a clinical perspective (English)

1 reference

inflammatory bowel diseases

25 August 2017

main subject

0 references

0 references

Simon Barry

5

0 references

author name string

Ian C Roberts-Thomson

1

1 reference

25 August 2017

James Fon

2

1 reference

25 August 2017

Wendy Uylaki

3

1 reference

25 August 2017

Adrian G Cummins

4

1 reference

25 August 2017

publication date

1 December 2011

1 reference

Expert Review of Gastroenterology & Hepatology

25 August 2017

published in

1 reference

25 August 2017

volume

5

1 reference

25 August 2017

issue

6

1 reference

25 August 2017

page(s)

703-716

1 reference

Pathogenesis of aphthoid ulcers in Crohn's disease: correlative findings by magnifying colonoscopy, electron microscopy, and immunohistochemistry

25 August 2017

cites work

1 reference

Type 1 T-helper cell predominance in granulomas of Crohn's disease

21 January 2018

1 reference

Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer

21 January 2018

1 reference

Resolution of inflammation: state of the art, definitions and terms

21 January 2018

1 reference

A calculated response: control of inflammation by the innate immune system

21 January 2018

1 reference

Origin and physiological roles of inflammation

21 January 2018

1 reference

Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators

21 January 2018

1 reference

Diet, gut microbiota and immune responses

21 January 2018

1 reference

Peripheral blood neutrophils in inflammatory bowel disease: morphological evidence of in vivo activation in active disease

21 January 2018

1 reference

Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin 10 during intestinal inflammation

21 January 2018

1 reference

Human neutrophil lipocalin is a unique marker of neutrophil inflammation in ulcerative colitis and proctitis

21 January 2018

1 reference

Defective acute inflammation in Crohn's disease: a clinical investigation

21 January 2018

1 reference

Role of scintigraphy in inflammatory bowel disease

21 January 2018

1 reference

Molecular fingerprints of neutrophil-dependent oxidative stress in inflammatory bowel disease

21 January 2018

1 reference

Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease

21 January 2018

1 reference

Phagocyte dysfunction and inflammatory bowel disease

21 January 2018

1 reference

The role of the macrophage in sentinel responses in intestinal immunity

21 January 2018

1 reference

Exploring the full spectrum of macrophage activation

21 January 2018

1 reference

A systems biology viewpoint on autophagy in health and disease

21 January 2018

1 reference

Human CD14+ macrophages in intestinal lamina propria exhibit potent antigen-presenting ability.

21 January 2018

1 reference

The immunology of mucosal models of inflammation

21 January 2018

1 reference

Stepwise regulation of TH1 responses in autoimmunity: IL-12-related cytokines and their receptors.

21 January 2018

1 reference

New players in the cytokine orchestra of inflammatory bowel disease

21 January 2018

1 reference

The role of T-regulatory cells and Toll-like receptors in the pathogenesis of human inflammatory bowel disease

21 January 2018

1 reference

Interplay between effector Th17 and regulatory T cells

21 January 2018

1 reference

21 January 2018

1 reference

Foxp3+ regulatory T cells, Th17 effector cells, and cytokine environment in inflammatory bowel disease.

21 January 2018

1 reference

Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases

21 January 2018

1 reference

The B-cell system in inflammatory bowel disease

21 January 2018

1 reference

Intestinal dendritic cells

21 January 2018

1 reference

Increased expression of CCL20 in human inflammatory bowel disease

21 January 2018

1 reference

Patients with active inflammatory bowel disease lack immature peripheral blood plasmacytoid and myeloid dendritic cells

21 January 2018

1 reference

Th1/Th17 immune response is induced by mesenteric lymph node dendritic cells in Crohn's disease.

21 January 2018

1 reference

Release of mast cell tryptase from human colorectal mucosa in inflammatory bowel disease

21 January 2018

1 reference

Plexitis as a predictive factor of early postoperative clinical recurrence in Crohn's disease.

21 January 2018

1 reference

Imbalance of NKp44(+)NKp46(-) and NKp44(-)NKp46(+) natural killer cells in the intestinal mucosa of patients with Crohn's disease.

21 January 2018

1 reference

Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis.

21 January 2018

1 reference

Deficiency of invariant natural killer T cells in coeliac disease

21 January 2018

1 reference

Intestinal epithelial cells in inflammatory bowel diseases

21 January 2018

1 reference

Mechanism of cytokine modulation of epithelial tight junction barrier

21 January 2018

1 reference

Heads up! How the intestinal epithelium safeguards mucosal barrier immunity through the inflammasome and beyond

21 January 2018

1 reference

TNF-mediated inflammatory disease.

21 January 2018

1 reference

Location of tumour necrosis factor alpha by immunohistochemistry in chronic inflammatory bowel disease

21 January 2018

1 reference

High levels of proinflammatory cytokines, but not markers of tissue injury, in unaffected intestinal areas from patients with IBD

21 January 2018

1 reference

Interfering with interferons in inflammatory bowel disease.

21 January 2018

1 reference

Local and systemic liberation of proinflammatory cytokines in ulcerative colitis

21 January 2018

1 reference

A dose escalating, placebo controlled, double blind, single dose and multidose, safety and tolerability study of fontolizumab, a humanised anti-interferon gamma antibody, in patients with moderate to severe Crohn's disease

21 January 2018

1 reference

Quantitative measurement of cytokine mRNA in inflammatory bowel disease: relation to clinical and endoscopic activity and outcome

21 January 2018

1 reference

Role of cytokines in inflammatory bowel disease

21 January 2018

1 reference

Decreased mucosal interleukin-4 (IL-4) production in gut inflammation

21 January 2018

1 reference

Il-6 signaling in inflammatory bowel disease: pathophysiological role and clinical relevance

21 January 2018

1 reference

Frequently relapsing Crohn's disease is characterized by persistent elevation in interleukin-6 and soluble interleukin-2 receptor serum levels during remission.

21 January 2018

1 reference

A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease

21 January 2018

1 reference

Inflammatory bowel disease and mutations affecting the interleukin-10 receptor

21 January 2018

1 reference

IL-10 family of cytokines

21 January 2018

1 reference

Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Crohn's Disease IL-10 Cooperative Study Group

21 January 2018

1 reference

Suppression of inflammation in ulcerative colitis by interferon- -1a is accompanied by inhibition of IL-13 production

21 January 2018

1 reference

Interleukin-23 and Th17 cells in the control of gut inflammation

21 January 2018

1 reference

Increased expression of interleukin 17 in inflammatory bowel disease

21 January 2018

1 reference

Differential mucosal expression of Th17-related genes between the inflamed colon and ileum of patients with inflammatory bowel disease

21 January 2018

1 reference

Translational mini-review series on Th17 cells: are T helper 17 cells really pathogenic in autoimmunity?

21 January 2018

1 reference

From IL-15 to IL-33: the never-ending list of new players in inflammation. Is it time to forget the humble aspirin and move ahead?

21 January 2018

1 reference

The Interleukin-23 / Interleukin-17 axis in intestinal inflammation.

21 January 2018

1 reference

A genome-wide association study identifies IL23R as an inflammatory bowel disease gene

21 January 2018

1 reference

Quantitive cytokine mRNA expression profiles in the colonic mucosa of patients with steroid naïve ulcerative colitis during active and quiescent disease

21 January 2018

1 reference

Late Crohn's disease patients present an increase in peripheral Th17 cells and cytokine production compared with early patients.

21 January 2018

1 reference

The increased mucosal mRNA expressions of complement C3 and interleukin-17 in inflammatory bowel disease.

21 January 2018

1 reference

Expression of interleukin-12-related cytokine transcripts in inflammatory bowel disease: elevated interleukin-23p19 and interleukin-27p28 in Crohn's disease but not in ulcerative colitis

21 January 2018

1 reference

Patients with inflammatory bowel disease may have a transforming growth factor-beta-, interleukin (IL)-2- or IL-10-deficient state induced by intrinsic neutralizing antibodies

21 January 2018

1 reference

Interleukin-10 in the pathophysiology of inflammatory bowel disease: increased serum concentrations during the recovery phase

21 January 2018

1 reference

A randomized trial of Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/EGH.11.74

1 reference

25 August 2017

1 reference